跳至主要内容
临床试验/EUCTR2009-016055-22-SE
EUCTR2009-016055-22-SE进行中(未招募)不适用

Hepatitis A vaccine in patients with immunomodulative drugs

HY, HUS0 个研究点目标入组 380 人开始时间: 2011年1月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diagnosis of rheumatoid arthritis
  • TNF-alfa blocker and / or methotraxate in use as a medication against RA
  • A desire to get protected against hepatitis A
  • Men and women age 18-65 years
  • Written informed consent
  • Women of childbearing potential must use effective contraception
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Treatment with rituximab within 9 months before study start
  • Known previous hepatitis A infection
  • Previous vaccination against hepatitis A
  • Egg-, henprotein- or formaldehyde allergy
  • Pregnancy or lactation
  • Excessive use of alcohol
  • An other vaccine given within a month
  • Mentally retardedness
  • Acute disease at the time of examination (fever > 38 degrees)
  • Volunteer works as an employee of the researchers
  • Previous vaccination against hepatitis A
  • Egg-, henprotein- or formaldehyde allergy
  • Pregnancy or lactation
  • Excessive use of alcohol
  • Immunological abnormality: immunosupression or autoimmune disease
  • An other vaccine given within a month
  • Mentally retardedness
  • Acute disease at the time of examination (fever > 38 degrees)
  • Employees of the researchers
  • Not suitable for other reason in the investigator's opinion (other serious disease, i.e. AIDS/HIV-positiv, cancer with ongoing cytostatic treatment)

研究者

发起方
HY, HUS

相似试验